Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 3.71 | N/A |
| PEG Ratio (TTM) | -1.97 | N/A |
| P/S Ratio (TTM) | 0.20 | N/A |
| P/B Ratio (TTM) | 1.55 | N/A |
| P/FCF Ratio (TTM) | 13.44 | N/A |
| Price to 5YR AVG Earnings Ratio | 9.14 | N/A |
| Price to 5YR AVG FCF Ratio | 19.58 | N/A |
Profitability (75%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 18.17% | N/A |
| ROE (TTM) | 40.87% | N/A |
| Net Profit Margin (TTM) | 5.35% | N/A |
| ROIC 5YR AVG | 30.49% | N/A |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 193.82% | 148.57% | 104.95% |
| Revenue | -12.11% | 4.14% | 3.03% |
| Net Income | 196.49% | 150.68% | 108.38% |
| Cash Flow | -40.31% | 57.63% | 23.25% |
Health (77%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.77 | N/A |
| Quick Ratio (TTM) | 1.77 | N/A |
| D/E Ratio (TTM) | 0.69 | N/A |
| Interest Coverage (TTM) | 4.23 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 5.79 | N/A |
| LTL to 5YR AVG FCF | 0.63 | N/A |
| Shares Outstanding Growth 5YR AVG | 2.46% | N/A |